Positron Emission Tomography-Computed Tomography Imaging, Genomic Profile, and Survival in Patients With Head and Neck Cancer Receiving Immunotherapy.
Where this comes from
- Record sourced from PubMed, PMID 34297796.
- Also identified by DOI 10.1001/jamaoto.2021.1763 and PMC identifier 8304169.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This study analyzes the association between maximum standardized uptake value on positron emission tomography–computed tomography and survival in patients with head and neck cancer who are receiving immune checkpoint inhibitor drugs.
Medical subject headings
- Biomarkers, Tumor
- Head and Neck Neoplasms
- Immune Checkpoint Inhibitors
- Positron Emission Tomography Computed Tomography
- Squamous Cell Carcinoma of Head and Neck